Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation

Human cytomegalovirus (HCMV) infection causes significant morbidity and mortality after hematopoietic stem cell transplantation (HSCT). In this work, we characterized the phenotype and interferon-gamma (INF-γ) production of HCMV-specific T cells using QuantiFERON-HCMV assay in 26 patients 6 months a...

Full description

Saved in:
Bibliographic Details
Main Authors: Inmaculada Gayoso, Sara Cantisán, Carolina Cerrato, Joaquín Sánchez-García, Carmen Martin, Rafael Solana, Antonio Torres-Gomez, Julian Torre-Cisneros
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/347213
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565117052518400
author Inmaculada Gayoso
Sara Cantisán
Carolina Cerrato
Joaquín Sánchez-García
Carmen Martin
Rafael Solana
Antonio Torres-Gomez
Julian Torre-Cisneros
author_facet Inmaculada Gayoso
Sara Cantisán
Carolina Cerrato
Joaquín Sánchez-García
Carmen Martin
Rafael Solana
Antonio Torres-Gomez
Julian Torre-Cisneros
author_sort Inmaculada Gayoso
collection DOAJ
description Human cytomegalovirus (HCMV) infection causes significant morbidity and mortality after hematopoietic stem cell transplantation (HSCT). In this work, we characterized the phenotype and interferon-gamma (INF-γ) production of HCMV-specific T cells using QuantiFERON-HCMV assay in 26 patients 6 months after HSCT. We analysed whether these two parameters were associated with clinical variables. Our results showed that the patients receiving stem cells from donors ≥40 years old were 12 times more likely to have HCMV-specific CD8+ T cells with “differentiated phenotype” (CD45RA+CCR7+ ≤6.7% and CD28+ ≤30%) than patients grafted from donors <40 years old (OR=12; P=0.014). In addition, a detectable IFN-γ production in response to HCMV peptides (cutoff 0.2 IU/mL IFN-γ; “reactive” QuantiFERON-HCMV test) was statistically associated with HCMV replication after transplantation (OR=11; P=0.026), recipients ≥40 versus <40 years old (OR=11; P=0.026), and the use of peripheral blood versus bone marrow as stem cell source (OR=17.5; P=0.024). In conclusion, donor age is the only factor significantly associated with the presence of the “differentiated phenotype” in HCMV-specific CD8+ T cells, whereas HCMV replication after transplantation, recipient age, and stem cell source are the factors associated with the production of IFN-γ in response to HCMV epitopes.
format Article
id doaj-art-a310bc398d784dc9a691eff7a56be619
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-a310bc398d784dc9a691eff7a56be6192025-02-03T01:09:23ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/347213347213Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells TransplantationInmaculada Gayoso0Sara Cantisán1Carolina Cerrato2Joaquín Sánchez-García3Carmen Martin4Rafael Solana5Antonio Torres-Gomez6Julian Torre-Cisneros7Instituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainInstituto Maimonides para la Investigacion Biomedica de Córdoba (IMIBIC), Reina Sofia University Hospital, 14004 Cordoba, SpainHuman cytomegalovirus (HCMV) infection causes significant morbidity and mortality after hematopoietic stem cell transplantation (HSCT). In this work, we characterized the phenotype and interferon-gamma (INF-γ) production of HCMV-specific T cells using QuantiFERON-HCMV assay in 26 patients 6 months after HSCT. We analysed whether these two parameters were associated with clinical variables. Our results showed that the patients receiving stem cells from donors ≥40 years old were 12 times more likely to have HCMV-specific CD8+ T cells with “differentiated phenotype” (CD45RA+CCR7+ ≤6.7% and CD28+ ≤30%) than patients grafted from donors <40 years old (OR=12; P=0.014). In addition, a detectable IFN-γ production in response to HCMV peptides (cutoff 0.2 IU/mL IFN-γ; “reactive” QuantiFERON-HCMV test) was statistically associated with HCMV replication after transplantation (OR=11; P=0.026), recipients ≥40 versus <40 years old (OR=11; P=0.026), and the use of peripheral blood versus bone marrow as stem cell source (OR=17.5; P=0.024). In conclusion, donor age is the only factor significantly associated with the presence of the “differentiated phenotype” in HCMV-specific CD8+ T cells, whereas HCMV replication after transplantation, recipient age, and stem cell source are the factors associated with the production of IFN-γ in response to HCMV epitopes.http://dx.doi.org/10.1155/2013/347213
spellingShingle Inmaculada Gayoso
Sara Cantisán
Carolina Cerrato
Joaquín Sánchez-García
Carmen Martin
Rafael Solana
Antonio Torres-Gomez
Julian Torre-Cisneros
Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
Clinical and Developmental Immunology
title Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
title_full Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
title_fullStr Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
title_full_unstemmed Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
title_short Clinical Factors Influencing Phenotype of HCMV-Specific CD8+ T Cells and HCMV-Induced Interferon-Gamma Production after Allogeneic Stem Cells Transplantation
title_sort clinical factors influencing phenotype of hcmv specific cd8 t cells and hcmv induced interferon gamma production after allogeneic stem cells transplantation
url http://dx.doi.org/10.1155/2013/347213
work_keys_str_mv AT inmaculadagayoso clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT saracantisan clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT carolinacerrato clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT joaquinsanchezgarcia clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT carmenmartin clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT rafaelsolana clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT antoniotorresgomez clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation
AT juliantorrecisneros clinicalfactorsinfluencingphenotypeofhcmvspecificcd8tcellsandhcmvinducedinterferongammaproductionafterallogeneicstemcellstransplantation